CureVac | 20-F: Registration statement / Annual report / Transition report
Apr 26 02:24
CureVac | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 25 10:22
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 25 04:25
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 25 04:21
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 17 04:21
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 13 04:53
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 5 04:18
CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(1.2%),Peter Kolchinsky(1.2%), etc.
Feb 15 06:32
CureVac | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-GSK plc(7.4%)
Feb 7 06:13
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 17 13:00
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Jan 5 13:00
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 13:00
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 13:00
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 13:00
CureVac | 144: Notice of proposed sale of securities pursuant to Rule 144
Jan 5 13:00
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Dec 20, 2023 05:30
CureVac | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 15, 2023 05:15
CureVac | 6-K: Report of foreign private issuer (related to financial reporting)
Nov 15, 2023 05:15
CureVac | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Nov 2, 2023 04:45
CureVac | UPLOAD: Others
Oct 20, 2023 03:36
No Data
No Data